{
    "clinical_study": {
        "@rank": "27009", 
        "brief_summary": {
            "textblock": "This study will collect blood from patients with cancer to study the level of cells which\n      decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18\n      years of age and older with cancer may participate. This study does not involve treatment.\n\n      Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their\n      condition, patients may be invited to enroll in a clinical research study involving\n      chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during\n      the course of treatment."
        }, 
        "brief_title": "Collection of Blood From Patients With Cancer", 
        "condition": [
            "Prostate Cancer", 
            "Breast Cancer", 
            "Colon Cancer", 
            "Lung Cancer", 
            "Liver Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Colonic Neoplasms", 
                "Liver Neoplasms", 
                "Lung Neoplasms", 
                "Prostatic Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with a prior diagnosis of malignancy or refractory cancer will be evaluated in the\n      Medical Oncology Clinic, NCI or Interventional Radiology, NIH Clinical Center.  Blood, urine\n      or saliva samples may be collected at the initial visit and at follow-up visits.  The\n      specimens will be processed and stored in one or more of these locations for use in research\n      efforts: Laboratory of Tumor Immunology and Biology, Clinical Pharmacology Program, NCI\n\n      Frederick, Dr. Tito Fojo   s laboratory and Dr. Jane Trepel   s Laboratory."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  INCLUSION CRITERIA:\n\n        Patients 18 years of age and older are eligible.\n\n        Patients must have a performance status of ECOG 0, 1, 2, or 3 for admission to this\n        protocol.\n\n        Patients with malignancy are eligible.\n\n        INCLUSION FOR APHERESIS:\n\n        Hemoglobin greater than or equal to 10 mg/dL and platelet count >  75,000/mm(3)\n\n        Weight greater than 25 kg\n\n        HIV negative\n\n        Prothrombin Time     within normal limits\n\n        Partial Thromboplastin Time     within normal limits\n\n        Medically indicated central line in place or adequate peripheral venous access\n\n        EXCLUSION CRITERIA:\n\n        Children will not be eligible."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 24, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00034216", 
            "org_study_id": "020179", 
            "secondary_id": "02-C-0179"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Suppressor Cells", 
            "T-Cells", 
            "CD4+/CD25+ Cells", 
            "Cancer", 
            "Malignancy", 
            "Blood Sample"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "link": {
            "description": "NIH Clinical Center Detailed Web Page", 
            "url": "http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2002-C-0179.html"
        }, 
        "location": {
            "contact": {
                "last_name": "For more information at the NIH Clinical Center contact National Cancer Institute Referral Office", 
                "phone": "(888) NCI-1937"
            }, 
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Collection of Blood, Tissue and Urine From Patients With Cancer", 
        "overall_contact": {
            "email": "smcmahon@mail.nih.gov", 
            "last_name": "Sheri A McMahon, R.N.", 
            "phone": "(301) 496-9812"
        }, 
        "overall_contact_backup": {
            "email": "gulleyj@mail.nih.gov", 
            "last_name": "James L Gulley, M.D.", 
            "phone": "(301) 435-2956"
        }, 
        "overall_official": {
            "affiliation": "National Cancer Institute (NCI)", 
            "last_name": "James L Gulley, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "primary_outcome": {
            "measure": "Analyze tissue, urine, saliva, and blood components, which include serum, leukocytes, and circulating tumor cells (cTC), of patients with cancer", 
            "safety_issue": "No", 
            "time_frame": "On-going"
        }, 
        "reference": [
            {
                "PMID": "10553041", 
                "citation": "Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol. 1999 Nov 15;163(10):5211-8."
            }, 
            {
                "PMID": "11390435", 
                "citation": "Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001 Jun 4;193(11):1285-94."
            }, 
            {
                "PMID": "11390436", 
                "citation": "Levings MK, Sangregorio R, Roncarolo MG. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med. 2001 Jun 4;193(11):1295-302."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00034216"
        }, 
        "secondary_outcome": [
            {
                "measure": "Assess the immunologic status of patients with muscle invasive bladder cancer at baseline during and after chemotherapy and post surgery to determine the best time to initiate concurrent or sequential immunotherapy", 
                "safety_issue": "No", 
                "time_frame": "On-going"
            }, 
            {
                "measure": "Correlate the immunologic subsets in blood with those present in tumor tissue", 
                "safety_issue": "No", 
                "time_frame": "On-going"
            }, 
            {
                "measure": "Assess the differences in immunologic subsets found with standard gemcitabine and cisplatin with those in dose dense gemcitabine and cisplatin", 
                "safety_issue": "No", 
                "time_frame": "On-going"
            }
        ], 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 2002", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }, 
    "geocoordinates": {
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095"
    }
}